On October 21, 2021 at an ACIP meeting for “COVID-19 Vaccine Safety Updates,” Dr Tom Shimabukuro, a member of the CDC COVID-19 Vaccine Task Force presented slides admitted that the COVID-19 vaccines can cause myocarditis and myopericarditis, especially in the young and after their second dose. [1, 2]

The comimittee ignored this like altering myocarditis risk, and 5 days later on October 26, 2021, ACIP approved the vaccine for children aged 5 to 11.